Your browser doesn't support javascript.
loading
Is Pertuzumab Plus Trastuzumab Without Chemotherapy a Reasonable Treatment for ERBB2-Positive Metastatic Breast Cancer?-Reply.
Huober, Jens; Thürlimann, Beat; Dietrich, Daniel.
Affiliation
  • Huober J; Breast Center St Gallen, Cantonal Hospital, St Gallen, Switzerland.
  • Thürlimann B; Swiss Breast Care, Klinik Bethanien, Zürich, Switzerland.
  • Dietrich D; Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, Bern, Switzerland.
JAMA Oncol ; 10(4): 537-538, 2024 Apr 01.
Article in En | MEDLINE | ID: mdl-38329767
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Limits: Female / Humans Language: En Journal: JAMA Oncol Year: 2024 Document type: Article Affiliation country: Switzerland Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Limits: Female / Humans Language: En Journal: JAMA Oncol Year: 2024 Document type: Article Affiliation country: Switzerland Country of publication: United States